ATE255587T1 - Trans-platinverbindung und diagnostischer testsatz - Google Patents

Trans-platinverbindung und diagnostischer testsatz

Info

Publication number
ATE255587T1
ATE255587T1 AT98912826T AT98912826T ATE255587T1 AT E255587 T1 ATE255587 T1 AT E255587T1 AT 98912826 T AT98912826 T AT 98912826T AT 98912826 T AT98912826 T AT 98912826T AT E255587 T1 ATE255587 T1 AT E255587T1
Authority
AT
Austria
Prior art keywords
test kit
diagnostic test
trans
trans platinum
platinum connection
Prior art date
Application number
AT98912826T
Other languages
English (en)
Inventor
Hendrik Jan Houthoff
Jan Reedijk
Herman H Volkers
Robert Jochem Heetebrij
Original Assignee
Kreatech Biotech Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kreatech Biotech Bv filed Critical Kreatech Biotech Bv
Priority claimed from PCT/NL1998/000206 external-priority patent/WO1998045304A1/en
Application granted granted Critical
Publication of ATE255587T1 publication Critical patent/ATE255587T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Interface Circuits In Exchanges (AREA)
AT98912826T 1997-04-10 1998-04-09 Trans-platinverbindung und diagnostischer testsatz ATE255587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201066A EP0870770A1 (de) 1997-04-10 1997-04-10 Trans-Platinverbindung, ein diese enthaltender, diagnostischer Kit, und ein Verfahren zur Markierung von bioorganischen Molekülen
PCT/NL1998/000206 WO1998045304A1 (en) 1997-04-10 1998-04-09 Trans-platinum compound, and diagnostic kit

Publications (1)

Publication Number Publication Date
ATE255587T1 true ATE255587T1 (de) 2003-12-15

Family

ID=8228196

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912826T ATE255587T1 (de) 1997-04-10 1998-04-09 Trans-platinverbindung und diagnostischer testsatz

Country Status (11)

Country Link
US (1) US6248531B1 (de)
EP (1) EP0870770A1 (de)
JP (1) JP4212652B2 (de)
AT (1) ATE255587T1 (de)
AU (1) AU737441B2 (de)
CA (1) CA2286668C (de)
DE (1) DE69820244T2 (de)
DK (1) DK0973785T3 (de)
ES (1) ES2212279T3 (de)
NZ (1) NZ500184A (de)
PT (1) PT973785E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811979B2 (en) * 2000-10-11 2004-11-02 Applera Corporation Fluorescent nucleobase conjugates having anionic linkers
WO2004027384A2 (en) * 2002-09-17 2004-04-01 Perkinelmer Life Sciences, Inc. Real-time detection of nucleic acid reactions
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
CA2531123A1 (en) * 2003-07-02 2005-01-13 Perkinelmer Las, Inc. Assay and process for labeling and detection of micro rna and small interfering rna sequences
EP1669760A1 (de) 2004-12-08 2006-06-14 Kreatech Biotechnology B.V. Markierte Übergangsmetall-Komplexe
EP1745802A1 (de) * 2005-07-20 2007-01-24 Kreatech Biotechnology B.V. Verfahren zur Konjugierung therapeutischer Verbindungen an zellgezielten Gruppen über Metallkomplexen
EP2800587A2 (de) 2012-01-06 2014-11-12 LinXis B.V. Verfahren zur herstellung von zelltarget-konjugaten und daraus gewonnenen komplexen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5107007A (en) * 1989-09-01 1992-04-21 The University Of Vermont And State Agricultural College Bis-platinum complexes as chemotherapeutic agents
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
US5521289A (en) * 1994-07-29 1996-05-28 Nanoprobes, Inc. Small organometallic probes
PT1019420E (pt) * 1995-05-09 2003-12-31 Kreatech Biotech Bv Metodos para a producao de ligandos baseados em platina para ligacao entre marcadores e moleculas bio-orgaicas na marcacao de moleculas bio-organicas com o fim de detectar substancias biologicas de interesse e conjuntos ("kits") de ensaios de diagnosticos

Also Published As

Publication number Publication date
JP2001521511A (ja) 2001-11-06
AU737441B2 (en) 2001-08-16
US6248531B1 (en) 2001-06-19
AU6751798A (en) 1998-10-30
DE69820244D1 (de) 2004-01-15
EP0870770A1 (de) 1998-10-14
NZ500184A (en) 2001-08-31
CA2286668C (en) 2008-05-06
JP4212652B2 (ja) 2009-01-21
DK0973785T3 (da) 2004-04-05
DE69820244T2 (de) 2004-09-09
PT973785E (pt) 2004-04-30
CA2286668A1 (en) 1998-10-15
ES2212279T3 (es) 2004-07-16

Similar Documents

Publication Publication Date Title
ATE296833T1 (de) Nukleinsäure-markierungsverbindungen
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
EP1219626A4 (de) Verbdindungen zur floureszenz-kennzeichnung
ATE113078T1 (de) Nukleinsäure-sandwichassay in lösungsphase und dafür geeignete polynukleotidprobe.
WO1999041273A3 (en) Pna and dna conjugates and methods for preparation thereof
ATE255587T1 (de) Trans-platinverbindung und diagnostischer testsatz
AU5197599A (en) Fluorescent labelling reagents
DE59705110D1 (de) Fluoreszenzkorrelationsspektroskopiemodul für ein mikroskop
DE59912117D1 (de) Sulfonylamino-carbonsäure-n-arylamide als guanylatcyclase-aktivatoren
AU3050800A (en) Functionalised polynucleotide compound, optionally marked and method for detecting a target nucleic acid
EP0283206A3 (de) Polysiloxane mit kovalent gebundenen Markierungsgruppen
ATE266065T1 (de) Tintenzusammensetzung enthaltend ein kationisches wasserlösliches harz und tiintensortiment
DK1262778T3 (da) Fremgangsmåde til differentieret mærkning ved anvendelse af platinkomplekser
DE59703671D1 (de) Für wasserbasislacke geeignetes n,n'-dimethylperylen-3,4,9,10-tetracarbonsäurediimidpigment
DE69419661D1 (de) Thiazolotriazol- und Thiazolodiazolderivate mit fungizider Aktivität
AU681727B2 (en) Method for the preparation of 2-perfluoroalkyl-3-oxazolin- 5-one
DE69418329D1 (de) Lumineszente Farbstoffe, aktive Elementen auf deren Grundlage und Messverfahren für die Sauerstoffkonzentration diese lumineszenten Farbstoffe benutzend
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
EP0994111A4 (de) Tetrahydrofuranderivate
WO2002100804A3 (en) Novel use of sulfamic acids as resolving agent.
EP0488778A3 (en) A radioactive iodine compound for labeling an antibody
UA3540S (uk) Етикетка для горілки "імперіал"
UA3219S (uk) Етикетка для вина "мускатель лівадія"
UA3507S (uk) Етикетка для вина "піно-грі"
BR9802329A (pt) Alfa-fenóxi-alcanóis, seus processosde preparo e suas aplicações.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0973785

Country of ref document: EP

REN Ceased due to non-payment of the annual fee